Elicio Therapeutics Inc
NASDAQ:ELTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biohit Oyj
OMXH:BIOBV
|
FI |
During the last 3 months Elicio Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 30% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/eltx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Aug 12, 2024
by
Gkcc, Llc
, who
bought
20m USD
worth of
ELTX shares.
During the last 3 months Elicio Therapeutics Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 30% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/nasdaq/eltx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Aug 12, 2024
by
Gkcc, Llc
, who
bought
20m USD
worth of
ELTX shares.
Elicio Therapeutics Inc
Glance View
Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. The company is headquartered in Boston, Massachusetts and currently employs 3 full-time employees. The company went IPO on 2021-02-05. The firm is engaged in developing a pipeline of immunotherapies for the treatment of cancer and other diseases. The company provides a platform, amphiphile (AMP) that delivers immuno therapeutics directly to the lymph nodes (brain center) of the immune system. The firm's lead product candidate, ELI-002, is being developed to treat cancers driven by kirsten rat sarcoma (KRAS). The company is conducting a Phase I/II clinical trial of ELI-002 (AMPLIFY-201). The firm is also evaluating the use of ELI-004, a universal AMP-modified clinical practice guidelines (CpG) adjuvant to treat or prevent additional diseases. The firm provides anaplastic lymphoma kinase (ALK) program to identify an internal development candidate. The firm conducts assessments for using ELI-004 to induce immune responses targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.